HCQS 200 Tablet is used to treat autoimmune conditions such as rheumatoid arthritis and systemic lupus erythematosus. It slows the disease's progression and relieves pain, swelling, and redness. It is also used in patients with type 2 diabetes mellitus to improve glycemic control.
HCQS 300 Tablet is used in the treatment of autoimmune conditions such as rheumatoid arthritis and systemic lupus erythematosus. It slows down the progression of the disease and provides relief from pain, swelling, and redness.
Baricitinib 4mg Tablet is a Janus kinase inhibitor used to treat moderate to severe rheumatoid arthritis. It helps decrease pain, tenderness, and swelling in the joints by reducing inflammation. It also helps slow the progression of bone and joint damage.
Artesunate 100 mg Tablet is an antiparasitic medication. It is used in the treatment of malaria. It is not used to prevent malaria or to treat severe malaria (where it has affected the brain, lungs or kidneys). Arnet 50mg Tablet should be used in the dose and duration as advised by your doctor. Take it with food, preferably at a fixed time. Do not skip any doses and finish the full course of treatment even if you feel better. Do not take a double dose to make up for a missed dose. Simply take the next dose as planned.
HCQS 400 Tablet is used in the treatment of autoimmune conditions such as rheumatoid arthritis and systemic lupus erythematosus. It slows down the progression of the disease and provides relief from pain, swelling, and redness.
Request Callback
Yes! I am Interested
Mebendazole 500 mg and Ivermectin 25mg
Get Best Quote
Approx. Price: Rs 341 / StripGet Latest Price
Product Details:
Strength
500 mg
Pack Size
10 Tablets
Brand
WIN LIFE
Form
Tablet
Indication
Worm Infestation
Packaging Type
Strip
Shelf Life
24 months
Mebenda Plus is a combination prescription antiparasitic medication containing 500 mg Mebendazole and 25 mg Ivermectin. It treats mixed intestinal and tissue worm infections (roundworms, hookworms, whipworms, threadworms) by starving them of glucose and paralyzing them. It is commonly used as a short-course therapy.
Nirmatrelvir is packaged with ritonavir (as Paxlovid), a strong cytochrome P450 (CYP) 3A4 inhibitor and pharmacokinetic boosting agent that has been used to boost HIV protease inhibitors. Coadministration of ritonavir is required to increase nirmatrelvir concentrations to the target therapeutic range.
Nirmatrelvir is a SARS-CoV-2 main protease inhibitor. It works by preventing the growth of the virus that causes COVID-19. Ritonavir increases ("boosts") the levels of nirmatrelvir. This helps nirmatrelvir work better.
